Incomplete stent apposition (ISA) and the absence of strut endothelialization might be linked to stent thrombosis. STEMI might have a higher risk of thrombosis. Methods: An early OCT evaluation of stents that were deployed in culprit lesions for STEMI was performed at 9-18days. The primary end-point was the percentage of incomplete stent apposition and that of struts covered with a thrombus. Secondary end-points were the percentage of neointima covered struts. Results: 20 lesions in 20 patients (4,614 struts) were analyzed. Median follow-up time was 12 (range 9 to 18) days. The frequency of incomplete stent apposition was 14%. The frequency of stent covered with thrombus was 11%. The percentage of incomplete stent apposition covered with thrombus and that of well apposition covered with thrombus were 73% and 27% (p< 0.05). Conclusions: Stents implanted for STEMI had a high frequency of incompletely apposed struts at early phase using OCT. These struts of incomplete stent apposition were obviously coated a thrombus compared with apposition struts at the early stage.
intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).
Incomplete stent apposition (ISA) and the absence of strut endothelialization might be linked to stent thrombosis. STEMI might have a higher risk of thrombosis. Methods: An early OCT evaluation of stents that were deployed in culprit lesions for STEMI was performed at 9-18days. The primary end-point was the percentage of incomplete stent apposition and that of struts covered with a thrombus. Secondary end-points were the percentage of neointima covered struts. Results: 20 lesions in 20 patients (4,614 struts) were analyzed. Median follow-up time was 12 (range 9 to 18) days. The frequency of incomplete stent apposition was 14%. The frequency of stent covered with thrombus was 11%. The percentage of incomplete stent apposition covered with thrombus and that of well apposition covered with thrombus were 73% and 27% (p< 0.05). Conclusions: Stents implanted for STEMI had a high frequency of incompletely apposed struts at early phase using OCT. These struts of incomplete stent apposition were obviously coated a thrombus compared with apposition struts at the early stage.
TCT-393
Relation between the SYNTAX score and culprit vessel vulnerability in non-ST-segment elevation acute coronary syndrome-An optical coherence tomography study Background: High SYNTAX score (SS) has been associated with increased incidences of major adverse cardiac events, even after successful percutaneous coronary intervention (PCI) for culprit lesions. optical coherence tomography (OCT) imaging is a feasible technique for the identification of thin-cap fibroatheroma (TCFA) in vivo and may provide a better understanding of vulnerable plaques. The aim of this study was to examine the relation between SS and culprit and non-culprit lesion morphology as evaluated by OCT in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). Methods: Culprit plaques in 144 patients with NSTEACS were interrogated by OCT before PCI. Non-culprit plaques were defined as independent plaques and had to be situated at least 5 mm from the stent edge in treated or non-treated vessels. A total of 81 non-culprit plaques in 81 patients were analyzed by OCT. Results: Patients were classified into 3 groups according to the tertile of SS: 48 patients with an SS of < 9; an intermediate SS group, 47 patients with an SS of !9 to < 16; and a high SS group, 49 patients with an SS of !16. Background: Incomplete strut coverage after drug-eluting stent (DES) implantation has been identified as an important predictor of late stent thrombosis.
Percutaneous coronary intervention (PCI) using DES in the setting of myocardial infarction causes a higher incidence of acute incomplete stent apposition (ISA), which may contribute to delayed healing. Guidance with optical coherence tomography (OCT) may lower the incidence of acute ISA and thereby provide better strut coverage. We assess the proportion of uncovered struts 6 months after OCT-versus angio-guided implantation of the Biolimus-eluting Nobori stent (BES) (Terumo) with biodegradable polymer in patients with Non-ST segment Elevation Myocardial Infarction. Methods: The OCTACS trial enrolled 100 patients. After obtainment of an optimal angiographic result, patients were randomized 1:1 to either (1) OCT-or (2) angioguided PCI. OCT was performed in both groups, and the operator was blinded to the OCT imaging in group 2. OCT-criteria indicating further intervention in group 1 were: Stent under expansion, acute ISA, significant edge dissection and/or significant residual stenosis. If criteria were met, additional balloon dilatation(s) and/or stenting was performed followed by a final OCT. Primary endpoint is difference in proportion of uncovered struts at 6 months. Results: Baseline characteristics were balanced between the OCT-vs. the angioguided group, including mean age (61.8AE9.4 years vs. 62.6AE11.0 years, p¼0.68, respectively). Further intervention was done in 46% of the OCT-guided patients, and maximal balloon pressures were significantly higher (16.8AE3.9 atm. vs. 15.0AE2.6 atm., p< 0.05), and procedure-and flouro times were substantially longer (46.0 (16.0-125.0) min. vs. 34.0 (17.0-99.0) min., p< 0.05 and 11.8AE7.2 min. vs. 8.4AE5.9 min., p< 0.05, respectively). Six months difference in proportion of uncovered struts and dynamic ISA patterns will be presented at TCT 2014. Conclusions: OCT guided BES implantation might contribute to better strut coverage by reducing the incidence of acute ISA.
TCT-395
Serial Optical Coherence Tomography Evaluation 6-, 12-and 24-month Follow-up after Nobori Biolimus A9-eluting Stent Implantation
Kobe University Graduate School of Medicine, Kobe-city, Hyogo
Background: Nobori is a novel biolimus A9-eluting stent (BES) coated with a biodegradable polymer only on the abluminal side. Long-term vessel healing after BES deployment remains unclear. Methods: Sixteen BES implanted in de novo coronary lesions of 13 patients were serially evaluated using optical coherence tomography (OCT) at 6, 12 and 24 months post-stenting. Average neointimal thickness, uncovered struts and neointimal unevenness score (NUS: each cross section as maximum neointimal thickness in one cross section divided by the average neointimal thickness of the same cross-section) were manually measured. In addition, the percentage of struts with peri-strut low intensity area (PLIA: a region around stent struts with a homogenous lower intensity appearance than surrounding tissue, which is suggestive of fibrin deposition or impaired neointimal maturation), thrombi and atherogenic neointima (AN: a neointima containing a diffuse border and poorsignal region with invisible struts underneath due to marked signal attenuation) were evaluated. Results: There was a significant increase in neointimal thickness (78AE22mm to 86AE25mm to 110AE32, p¼0.001) from the 6-to the 24-month follow-up, without a significant decrease in mean lumen area (5.95 AE 1.76 mm2 to 5.66AE 1.73 mm2 to 5.46 AE 1.88, p¼0.74). The incidences of uncovered struts and NUS significantly decreased from the 6-to the 24-month (4.22AE3.84% to 1.43AE1.64% to 0.40AE0.81, p¼0.001 and 2.02AE0.19% to 1.89AE0.22% to 1.77AE0.21, p¼0.006, respectively). % strut with PLIA decreased significantly during the follow-up (5.26 AE 4.85% to 3.49 AE 4.12% to 0.01 AE 0.01, p¼0.001) and thrombi also numerically decreased (7% to 0% to 0%, p¼0.37). There observed no AN in the current study subjects.
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